Home > Healthcare > Biotechnology > Bioservices > Biopreservation Market
Biopreservation Market size surpassed USD 4.5 billion in 2021 and is expected to grow at over 8% CAGR between 2022 and 2030. Growing prevalence of chronic diseases will drive the global market expansion.
Biopreservation extends the shelf life of food by adding natural or controlled antimicrobials or microbiota. The surging demand for biopreservatives in the pharmaceutical industry will foster market outlook. The growing number of people diagnosed with chronic diseases, such as diabetes, heart diseases, and ailments affecting the joints, nerves, bones, and more, will amplify the adoption of regenerative therapies. Biopreservation techniques are vital for regenerative medicines in order to maintain their integrity and functionality.
Additionally, the development of next-generation cryopreservation methods, upgradation of hypothermic storage formulation, and integration and design of nanoscale technologies have encouraged pharmaceutical companies, biotechnology firms, and hospitals to adopt in-house systems of the samples, fueling market value.
Report Attribute | Details |
---|---|
Base Year: | 2021 |
Biopreservation Market Size in 2021: | USD 4.5 Billion |
Forecast Period: | 2022 to 2030 |
Forecast Period 2022 to 2030 CAGR: | 8% |
2030 Value Projection: | USD 9.5 Billion |
Historical Data for: | 2017 to 2021 |
No. of Pages: | 260 |
Tables, Charts & Figures: | 426 |
Segments covered: | Product, Application, Cell provider, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Favorable government initiatives and growing adoption of biopreservation techniques from the world's expanding biobanks for the preservation of plasma, cells, tissue, and DNA will also promote biopreservation market growth. The companies in the field are majorly engaging in rigorous research and development activities, along with strategic mergers, acquisitions, and partnerships, to maintain their business standing.